Trang 1
Passage 3 Human Guinea Pig 1 SECTION 3 READING PASSAGE 3 You should spend about 20 minutes on Question 29-40 which are based on Reading Passage 3 below. Human Guinea Pig There are 50 million people in the world being used as guinea pigs in clinical trials testing experimental drugs. Apart from potentially risking part of their lives, applicants must pass a severe series of tests just to be able to participate in some trials. However, acceptance means more tests, negative side effects and a considerable disturbance to their daily lives. So what’s in it for them? As journalist Alex O’Meara explains in Chasing Medical Miracles, some participate out of genuine altruism, whilst some are looking for cures for their own disorders. O’Meara having diabetes himself volunteered for a risky transplant of insulin-producing cells from the liver, and his story spread through the book. O’Meara knows people choose to participate for life’s great motivator: money. Clinical trials are a huge business, making up to $24 billion annually, and the cash they offer as compensation has become a sought-after way to make extra money. This exchange of money often involves people who are sick and vulnerable and emphasises the dark ethical waters in which current clinical trials are mired. At intervals, the ill feel compelled to join a trial to get medical care. Some unethical researchers, desperate to recruit the large numbers needed to make their researchers statistically valid, take advantage of this. It can be difficult for ill people to take that, at best, they are taking experimental medicine and at worst they are taking nothing at all. Desperation for money or medicine is never a basis for unbiased decision-making. How can a researcher be sure a person is giving their true consent? And if a person gets better as a result of taking an experimental drug, what happens when their drug supply finishes after the trial? These ethical quandaries have influenced healthcare in develop countries where clinical trials are a prospering industry. According to Adriana Petryna in When Experiments Travel, in spite of the fact that drug companies are moving their trials to developing countries, only 10% of drug research addresses disorders that influence the world’s poor. Such diseases make up to 90% of the global disease burden. Establishing ethical and legal responsibilities is also becoming harder, she reports. With an increased

Bình luận (0)
Chưa có bình luận nào. Hãy là người đầu tiên!